It was reported that the CD4+CD25+ Treg cell population is generally increased in the peripheral blood and tumor tissue of patients with stomach cancer, lung cancer, liver cancer, colon cancer, melanoma, and other types of cancer. This evidence concerns the gene CD4 and neoplasm.